Worldwide Molecular Diagnostics Markets to 2024 - A 2019 Study Featuring 137 Key & Niche Market Player Profiles - ResearchAndMarkets.com

DUBLIN--()--The "Molecular Diagnostics - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets in US$ Thousand by the following Applications:

  • Infectious Disease Testing
  • Blood Screening
  • Cancer Screening
  • Other Applications

The report profiles 137 companies including many key and niche players such as:

  • Abbott Laboratories (USA)
  • Abbott Molecular (USA)
  • Becton, Dickinson and Company (USA)
  • bioMrieux SA (France)
  • Cepheid (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Grifols International, S.A. (Spain)
  • Hologic, Inc. (USA)
  • QIAGEN N.V. (The Netherlands)
  • QuestDiagnostics, Inc. (USA)
  • Siemens Healthcare GmBH (Germany)
  • Tecan Group Ltd. (Switzerland)
  • The ELITechGroup (France)
  • Thermo Fisher Scientific (USA)

Topics Covered

1. Global Market Overview

2. Growth Drivers and Market Trends

  • Aging Population Drives Molecular Diagnostics Market
  • Global Aging Population Statistics
  • Technological Innovations Set to Drive the Market
  • The Role of Molecular Diagnostics in Personalized Medicine
  • Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
  • Companion Diagnostics Drive Personalized Medicine
  • List of FDA Approved Complementary and Companion Diagnostic Assays
  • Biomarkers as Companion Diagnostics
  • Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth
  • Proteomics Technologies: Growing in Significance
  • New Developments in Proteomics Technologies
  • New Applications Hold Promising Potential
  • Molecular Diagnostics for Lymphoid Malignancies
  • Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
  • Select NGS Platforms Available in the Market
  • Rising Emphasis on Lab Automation to Augur Well for Market Growth
  • List of Fully Automated and Rapid Molecular Diagnostics
  • Molecular Diagnostics and Intellectual Property

3. Application Areas of Molecular Diagnostics

4. Competition in the Molecular Diagnostics Market

5. Product & Technology Overview

6. Product Approvals/Introductions

7. Recent Industry Activity

8. Focus on Select Global Players

9. Global Market Perspective

Total Companies Profiled: 137 (including Divisions/Subsidiaries 158)

  • The United States (95)
  • Canada (3)
  • Japan (1)
  • Europe (47)
    • France (5)
    • Germany (11)
    • The United Kingdom (9)
    • Italy (2)
    • Spain (1)
    • Rest of Europe (19)
  • Asia-Pacific (Excluding Japan) (11)
  • Middle East (1)

For more information about this report visit https://www.researchandmarkets.com/research/sz8c9g/worldwide?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics